ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
101 hedge funds and large institutions have $126M invested in Endocyte, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less call options, than puts
Call options by funds: $4.89M | Put options by funds: $14.2M
76% less capital invested
Capital invested by funds: $535M → $126M (-$409M)
Holders
101
Holding in Top 10
1
Calls
$4.89M
Puts
$14.2M
Top Buyers
| 1 | +$5.72M | |
| 2 | +$3.06M | |
| 3 | +$1.88M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$1.39M |
| 5 |
Renaissance Technologies
New York
|
+$1.39M |
Top Sellers
| 1 | -$16M | |
| 2 | -$14.8M | |
| 3 | -$11.2M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$10.4M |
| 5 |
PA
Perceptive Advisors
New York
|
-$10.4M |